Retina-The Journal of Retinal and Vitreous Diseases最新文献

筛选
英文 中文
Doppler Ultrasound Twinkling Artifact in Retinoblastoma. 视网膜母细胞瘤中的多普勒超声闪烁伪影
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-23 DOI: 10.1097/IAE.0000000000004262
Monica Lewis, Alex Brown, Monique Riemann, Luis F Goncalves, Aparna Ramasubramanian
{"title":"Doppler Ultrasound Twinkling Artifact in Retinoblastoma.","authors":"Monica Lewis, Alex Brown, Monique Riemann, Luis F Goncalves, Aparna Ramasubramanian","doi":"10.1097/IAE.0000000000004262","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004262","url":null,"abstract":"","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CHARACTERISTICS OF 'NOTCH' IN RETINOPATHY OF PREMATURITY FOLLOWING INTRAVITREAL RANIBIZUMAB MONOTHERAPY. 玻璃体内雷尼珠单抗单药治疗早产儿视网膜病变的 "缺口 "特征。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-23 DOI: 10.1097/IAE.0000000000004231
Fengjun Zhang, Qiong Zou, Qiuping Liu, Zhipeng You
{"title":"CHARACTERISTICS OF 'NOTCH' IN RETINOPATHY OF PREMATURITY FOLLOWING INTRAVITREAL RANIBIZUMAB MONOTHERAPY.","authors":"Fengjun Zhang, Qiong Zou, Qiuping Liu, Zhipeng You","doi":"10.1097/IAE.0000000000004231","DOIUrl":"10.1097/IAE.0000000000004231","url":null,"abstract":"<p><strong>Purpose: </strong>To explore the clinical features and significance of \"notch\" in reactivation of retinopathy of prematurity (ROP) post-intravitreal ranibizumab (IVR) monotherapy.</p><p><strong>Methods: </strong>Ninety-six infants (173 eyes) with type 1 or aggressive ROP (A-ROP) post-IVR monotherapy were retrospectively analyzed; 51 eyes were notch (+) and 122 eyes were notch (-). General demographics and clinical outcomes were compared by notch status for type 1 and A-ROP.</p><p><strong>Results: </strong>The notch primarily appeared in stage 2 ROP (84.4 and 78.9%) at the junction of zones I and II (68.8 and 63.2%) on the temporal side in type 1 ROP and A-ROP. Notch was present in the type 1 ROP group before first IVR but post-treatment in the A-ROP group. A significantly higher reactivation rate, longer follow-up duration, and postmenstrual age at last follow-up were seen in the notch (+) versus the notch (-) group. In the notch (+) ROP group, the mean gestational age (28.34±0.93 vs. 29.94±1.48 weeks) was significantly lower in reactivated versus regressed eyes.</p><p><strong>Conclusion: </strong>Notches appeared at different times but similar locations in type 1 ROP and A-ROP. The reactivation rate after IVR was increased in ROP with notches. Notch may be a useful biomarker for reactivation after IVR in ROP.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sparing versus Removal of Epiretinal Proliferation in the Surgical Repair of Full-thickness Macular Holes. 全厚黄斑孔手术修复中保留与去除视网膜外增殖的比较
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-23 DOI: 10.1097/IAE.0000000000004261
Masaki Fukushima, Kotaro Tsuboi, Ryota Akai, Yuichiro Ishida, Shunji Kusaka, Motohiro Kamei, Atsushi Hayashi, Taku Wakabayashi
{"title":"Sparing versus Removal of Epiretinal Proliferation in the Surgical Repair of Full-thickness Macular Holes.","authors":"Masaki Fukushima, Kotaro Tsuboi, Ryota Akai, Yuichiro Ishida, Shunji Kusaka, Motohiro Kamei, Atsushi Hayashi, Taku Wakabayashi","doi":"10.1097/IAE.0000000000004261","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004261","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the efficacy of vitrectomy with epiretinal proliferation (EP) sparing for full-thickness macular hole (FTMH) accompanied by EP.</p><p><strong>Methods: </strong>A multicenter, retrospective study. Eyes were divided into two groups: the sparing group (Group S) included eyes in which the EP around the hole was peeled and preserved, whereas the removal group (Group R) included eyes in which the EP was partially or completely removed. The internal limiting membrane was peeling in all eyes.</p><p><strong>Results: </strong>Forty-six eyes were included. Twenty-five eyes were in Group S, and 21 eyes were in Group R, with no difference in preoperative best-corrected visual acuity (BCVA) (P = 0.96). After primary surgery, MHs were closed in all eyes, and there were no complications in either group. Postoperative 12-month BCVA significantly improved in both groups (both P < 0.01), while Group S had better 12-month BCVA than Group R (P = 0.016). In the multivariable analysis, EP sparing was associated with better BCVA at 12 months (P = 0.006) after accounting for the minimal macular hole size and preoperative BCVA.</p><p><strong>Conclusions: </strong>EP sparing and removal were both safe and effective techniques, while EP sparing may provide a favorable outcome for eyes with FTMH and EP.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Higher subfoveal choroidal thickness in choroidal melanomas than in choroidal nevi. 脉络膜黑色素瘤的眼底脉络膜厚度高于脉络膜痣。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-22 DOI: 10.1097/IAE.0000000000004254
Abdelmajid Benlarbi, Denis Malaise, Juliana Estrada Walker, François Apéré, Livia Lumbroso-Le Rouic, Francine Behar-Cohen, Nathalie Cassoux, Alexandre Matet
{"title":"Higher subfoveal choroidal thickness in choroidal melanomas than in choroidal nevi.","authors":"Abdelmajid Benlarbi, Denis Malaise, Juliana Estrada Walker, François Apéré, Livia Lumbroso-Le Rouic, Francine Behar-Cohen, Nathalie Cassoux, Alexandre Matet","doi":"10.1097/IAE.0000000000004254","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004254","url":null,"abstract":"<p><strong>Purpose: </strong>To compare subfoveal choroidal thickness (SFCT) between eyes with choroidal melanoma and choroidal nevi.</p><p><strong>Methods: </strong>Retrospective study of 126 consecutive patients in a tertiary ocular oncology center. Eyes with tumors located less than two disc-diameters from the fovea were excluded. In eyes with naevi, factors of potential transformation into melanoma were recorded (orange pigment, subretinal fluid, thickness >2 mm, diameter >5 mm, ultrasound hollowness). SFCT was assessed by 3 independent observers on horizontal spectral-domain OCT scans.</p><p><strong>Results: </strong>Sixty-seven eyes with choroidal melanoma and 59 eyes with choroidal nevi were included. The melanoma and nevi groups did not differ in gender (P=0.14) nor age (P=0.34). There was a very good agreement between the three independent observers for SFCT measurements (intraclass correlation coefficient=0.89). Mean SFCT was higher in melanomas (294.3±89.9 µm) than naevi (260.3±76.7 µm) (P=0.013), and the difference remained significant between melanomas and 28 naevi with ≥2 growth risk factors (256.3±77.0 µm) (P=0.027). In a multivariate model, the significant contributors to SFCT were presence of melanoma (P=0.004), younger age (P<0.0001) and shorter lesion distance to the fovea (P=0.016).</p><p><strong>Conclusion: </strong>SFCT may reflect the interplay between melanocytic tumors and their choroidal microenvironment. Its clinical utility should be explored in future studies.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The efficacy of intravitreal anti-VEGF for radiation maculopathy: a systematic review and meta-analysis. 玻璃体内抗血管内皮生长因子治疗辐射性黄斑病变的疗效:系统综述和荟萃分析。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-22 DOI: 10.1097/IAE.0000000000004255
Sheng-Chu Chi, Hsin-Ho Chang
{"title":"The efficacy of intravitreal anti-VEGF for radiation maculopathy: a systematic review and meta-analysis.","authors":"Sheng-Chu Chi, Hsin-Ho Chang","doi":"10.1097/IAE.0000000000004255","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004255","url":null,"abstract":"<p><strong>Background: </strong>Anti-vascular endothelial growth factor (VEGF) therapy is the primary approach for managing radiation maculopathy. However, a noticeable gap exists in meta-analyses evaluating the efficacy of anti-VEGF therapy specifically in the context of radiation maculopathy.</p><p><strong>Methods: </strong>We conducted a review of comparative studies on anti-VEGF treatment up to October 2023. References were sourced from PubMed, EMBASE, and the Cochrane Library. The Cochrane Risk of Bias tool assessed the quality of randomized controlled trials (RCTs), while the Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool evaluated non-RCTs.</p><p><strong>Results: </strong>Thirteen articles originating from eleven trials involving 2,525 eyes of 2408 patients were included. Four trials with 2226 eyes examined the effect of preventive anti-VEGF. Four trials with 189 eyes assessed the effect of anti-VEGF for preexisting maculopathy, and three trials with 110 eyes compared different anti-VEGF treatment modalities. In the preventive anti-VEGF treatment meta-analysis over a 24-month follow-up, the anti-VEGF group exhibited significantly fewer cases of radiation maculopathy (OR: 0.40; 95% CI: 0.25, 0.66, P= .0003, I2 =45%). For the meta-analysis of anti-VEGF treatment for pre-existing radiation maculopathy over a 6-month follow-up, the anti-VEGF group showed improved visual acuity (SMD: -1.13, 95% CI: -1.69 to -0.56, P < .0000, I2 = 47%) and decreased central macular thickness (SMD: -0.59, 95% CI: -1.13 to -0.05, P = 0.03, I2 = 62%).</p><p><strong>Conclusion: </strong>Prophylactic anti-VEGF effectively prevents radiation maculopathy and is also beneficial in treating pre-existing radiation maculopathy. Intensive treatment initially provides early benefits, but the efficacy diminishes after transitioning to a treat-and-extend regimen.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unilateral scleral icterus due to spontaneous suprachoroidal hemorrhage. 自发性脉络膜上腔出血导致单侧巩膜黄疸。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-21 DOI: 10.1097/IAE.0000000000004260
William Foulsham, Luis Martinez-Velazquez, Kenneth Matthew McKay
{"title":"Unilateral scleral icterus due to spontaneous suprachoroidal hemorrhage.","authors":"William Foulsham, Luis Martinez-Velazquez, Kenneth Matthew McKay","doi":"10.1097/IAE.0000000000004260","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004260","url":null,"abstract":"","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical outcomes and intraoperative parameters of 3D visualization system versus conventional microscopes for macular surgery in highly myopic eyes, a prospective randomized clinical trial. 高度近视眼黄斑手术中三维可视化系统与传统显微镜的手术效果和术中参数的前瞻性随机临床试验。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-21 DOI: 10.1097/IAE.0000000000004207
Mei-Chi Tsui, Yi-Ting Hsieh, Tso-Ting Lai, Cheng-Yung Lee, Yun Hsia, Shih-Wen Wang, I-Hsin Ma, Kuo-Chi Hung, Chang-Pin Lin, Chang-Hao Yang, Chung-May Yang, Tzyy-Chang Ho
{"title":"Surgical outcomes and intraoperative parameters of 3D visualization system versus conventional microscopes for macular surgery in highly myopic eyes, a prospective randomized clinical trial.","authors":"Mei-Chi Tsui, Yi-Ting Hsieh, Tso-Ting Lai, Cheng-Yung Lee, Yun Hsia, Shih-Wen Wang, I-Hsin Ma, Kuo-Chi Hung, Chang-Pin Lin, Chang-Hao Yang, Chung-May Yang, Tzyy-Chang Ho","doi":"10.1097/IAE.0000000000004207","DOIUrl":"10.1097/IAE.0000000000004207","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the surgical outcomes and intraoperative parameters of 3D visualization system for macular diseases in highly myopic eyes.</p><p><strong>Methods: </strong>In this single-center, prospective, randomized, comparative interventional study, 40 highly myopic eyes (axial length > 26mm) were randomly assigned to either a 3D visualization system or a conventional microscope (CM) group. Surgical outcomes and intraoperative parameters, including the number of indocyanine green (ICG) injections, surgical time, and epiretinal membrane (ERM)/ internal limiting membrane (ILM) peeling time, were compared.</p><p><strong>Results: </strong>The 3D group required significantly fewer ICG injections (1.3 ± 0.5 vs. 2.3 ± 0.7, p < 0.001), had shorter ERM/ILM peeling times (522.8 ± 258.0 vs. 751.8 ± 320.2 sec, p < 0.05), and experienced fewer intraoperative retinal hemorrhages (0 vs. 7 cases, p < 0.05) compared to the CM group. Anatomical and functional outcomes were comparable between the two groups.</p><p><strong>Conclusion: </strong>The 3D system exhibited a lower number of ICG injections, shorter ERM/ILM peeling times and a reduced incidence of intraoperative retinal hemorrhages, suggesting the 3D visualization system may offer advantages for macular surgery in highly myopic eyes.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vascular Changes and Irreversible Complications in 120° Fundus Using Widefield SS-OCTA in Vogt-Koyanagi-Harada Disease. 在 Vogt-Koyanagi-Harada 病中使用宽域 SS-OCTA 观察 120° 眼底的血管变化和不可逆并发症。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-21 DOI: 10.1097/IAE.0000000000004259
Suo Guo, Lan Xia, Rong Hu, Jing Wang, Peizeng Yang
{"title":"Vascular Changes and Irreversible Complications in 120° Fundus Using Widefield SS-OCTA in Vogt-Koyanagi-Harada Disease.","authors":"Suo Guo, Lan Xia, Rong Hu, Jing Wang, Peizeng Yang","doi":"10.1097/IAE.0000000000004259","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004259","url":null,"abstract":"<p><strong>Purpose: </strong>To characterize the changes of fundus corresponding to 120° field of view in chronic Vogt-Koyanagi-Harada (VKH) disease in the quiescent phase, and explore the associations with irreversible complications in the fundus utilizing widefield swept source optical coherence tomography angiography (SS-OCTA).</p><p><strong>Methods: </strong>Prospective cross-sectional study. Sixty-nine chronic VKH patients (115 eyes) and 55 healthy controls (110 eyes) were included and underwent widefield SS-OCTA. Univariate analyses of variations in retinal and choroidal vessel density (VD), choroidal volume, and choroidal vascularity index (CVI) in VKH patients with different disease durations and the controls were conducted. Logistic regression analysis was employed to identify the associations with irreversible complications including choroidal neovascularization, vasoproliferative tumour of the retina, and chorioretinal atrophy.</p><p><strong>Results: </strong>The Welch's analysis of variance showed lower VD of superficial retina, deep retina, choriocapillaris, and large-sized and medium-sized vessels of the choroid (LMVC), and choroidal volume and CVI in the patients with disease duration > 24 months compared to those with disease duration ≤ 24 months (all P≤0.011). The regression analysis revealed the disease duration (P=0.008; OR=1.02, 95%CI=1.005-1.035) and VD of LMVC (P=0.001; OR=0.707, 95%CI=0.575-0.87) were significantly correlated with the irreversible complications.</p><p><strong>Conclusions: </strong>Chronic VKH patients in the quiescent phase with disease duration > 24 months exhibit more severe decreased VD in each layer of the retina and choroid, reduced choroidal volume and sparse choroidal vascularity compared to those with disease duration ≤ 24 months. Prolonged duration and decreased VD of LMVC were associated with irreversible complications in the fundus.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Pro Re Nata versus Treat-and-Extend Anti-VEGF Injections for Myopic Macular Neovascularization in Multiethnic Patients in the United States. 美国多种族近视患者接受 Pro Re Nata 与治疗并延长抗血管内皮生长因子注射治疗近视黄斑新生血管的疗效对比。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-20 DOI: 10.1097/IAE.0000000000004256
Shreya Swaminathan, Raziyeh Mahmoudzadeh, Taku Wakabayashi, Mallory Bowers, Bita Momenaei, Robert M Abishek, Mirataollah Salabati, Jason Hsu, James P Dunn
{"title":"Outcomes of Pro Re Nata versus Treat-and-Extend Anti-VEGF Injections for Myopic Macular Neovascularization in Multiethnic Patients in the United States.","authors":"Shreya Swaminathan, Raziyeh Mahmoudzadeh, Taku Wakabayashi, Mallory Bowers, Bita Momenaei, Robert M Abishek, Mirataollah Salabati, Jason Hsu, James P Dunn","doi":"10.1097/IAE.0000000000004256","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004256","url":null,"abstract":"<p><strong>Purpose: </strong>To compare visual outcomes and recurrence rates between pro re nata (PRN), treat-and-extend and stop (TES), and treat-and-extend with chronic maintenance dosing (TEM) regimens of anti-vascular endothelial growth factor (VEGF) injections for myopic macular neovascularization (MNV) in multiethnic patients.</p><p><strong>Methods: </strong>This retrospective study included patients treated with PRN, TES, or TEM for myopic MNV using intravitreal bevacizumab or ranibizumab. The primary outcome measure was visual improvement at 12 months.</p><p><strong>Results: </strong>We included 127 eyes of 117 patients (75 females and 42 males). The mean follow-up duration was 37.9 months. We compared the outcomes of PRN (47 eyes [37%]), TES (52 eyes [41%]), and TEM (28 eyes [22%]). All groups showed significant visual improvement at 12 months and at the final follow-up (all P<0.05). Visual outcomes did not differ significantly between the three groups at 12 months and final follow-up (all P>0.05). However, the number of eyes with recurrences was significantly higher in the PRN group and significantly lower in the TEM group during follow-up (38%, 21%, and 11% in the PRN, TES, and TEM groups, respectively; P=0.020). The PRN group received the fewest injections during follow-up (5.3, 10.9, and 19.9 injections in the PRN, TES, and TEM groups respectively; P<0.001).</p><p><strong>Conclusions: </strong>Anti-VEGF injections with PRN, TES, or TEM regimens are effective for myopic MNV and have comparable visual outcomes. Since PRN provides favorable outcomes with fewer injections, it should be the first-line approach. However, a treat-and-extend approach with TES and TEM may be an option given individual patient factors.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SPECTRAL-DOMAIN OCT INSIGHTS INTO IDIOPATHIC EPIRETINAL MEMBRANE SURGERY OUTCOMES. 光谱域八度成像对特发性视网膜外膜手术效果的影响。
IF 2.3 2区 医学
Retina-The Journal of Retinal and Vitreous Diseases Pub Date : 2024-08-20 DOI: 10.1097/IAE.0000000000004258
Raquel Mansilla, Manuel F Bande, Purificación Mera, Francisco Ruiz-Oliva, Joaquin Marticorena, María José Blanco-Teijeiro
{"title":"SPECTRAL-DOMAIN OCT INSIGHTS INTO IDIOPATHIC EPIRETINAL MEMBRANE SURGERY OUTCOMES.","authors":"Raquel Mansilla, Manuel F Bande, Purificación Mera, Francisco Ruiz-Oliva, Joaquin Marticorena, María José Blanco-Teijeiro","doi":"10.1097/IAE.0000000000004258","DOIUrl":"https://doi.org/10.1097/IAE.0000000000004258","url":null,"abstract":"<p><strong>Purpose: </strong>This study aims to assess the prognostic value of a classification system that includes the presence of ectopic inner foveal layers (EIFL) and other anatomical variables identified in spectral-domain optical coherence tomography (SD-OCT) for idiopathic epiretinal membrane (ERM) surgery.</p><p><strong>Methods: </strong>A descriptive-analytic, longitudinal, retrospective study was conducted on patients with idiopathic ERMs treated with pars plana vitrectomy (PPV) from January 2017 to December 2021. Clinical data and SD-OCT images were reviewed pre-surgery and 12 months post-surgery. The primary outcome measured was best corrected visual acuity (BCVA) before and after surgery, analyzing the impact of anatomical factors on BCVA in patients undergoing ERM surgery.</p><p><strong>Results: </strong>The study included 342 eyes from 323 patients. Post-surgical evaluations showed significant reductions in central foveal thickness (CFT) across all ERM stages, with most stage 4 ERMs regressing to stage 3. The mean improvement in BCVA was significant for all stages, with earlier stages showing better results. Presence of macular edema (ME) and ellipsoid zone (EZ) disruption were significant predictors of post-surgical BCVA, while disorganization of the retinal inner layer (DRIL) showed association with visual recovery but was not conclusively predictive.</p><p><strong>Conclusion: </strong>The study highlights the importance of SD-OCT in assessing retinal changes in idiopathic ERMs, demonstrating the prognostic value of EIFL stage scheme and other anatomical variables like EZ disruption and ME presence on BCVA. These findings offer insights for surgical prognostication and the potential for personalized treatment strategies.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3,"publicationDate":"2024-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142037687","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信